87 related articles for article (PubMed ID: 19702294)
1. Evaluation of an Artificial Neural Network Retention Index Model for Chemical Structure Identification in Nontargeted Metabolomics.
Samaraweera MA; Hall LM; Hill DW; Grant DF
Anal Chem; 2018 Nov; 90(21):12752-12760. PubMed ID: 30350614
[TBL] [Abstract][Full Text] [Related]
2. Does the mass spectrometer define the marker? A comparison of global metabolite profiling data generated simultaneously via UPLC-MS on two different mass spectrometers.
Gika HG; Theodoridis GA; Earll M; Snyder RW; Sumner SJ; Wilson ID
Anal Chem; 2010 Oct; 82(19):8226-34. PubMed ID: 20828141
[TBL] [Abstract][Full Text] [Related]
3. Fragmentation trees for the structural characterisation of metabolites.
Kasper PT; Rojas-Chertó M; Mistrik R; Reijmers T; Hankemeier T; Vreeken RJ
Rapid Commun Mass Spectrom; 2012 Oct; 26(19):2275-86. PubMed ID: 22956319
[TBL] [Abstract][Full Text] [Related]
4. Demonstrating the reliability of in vivo metabolomics based chemical grouping: towards best practice.
Viant MR; Amstalden E; Athersuch T; Bouhifd M; Camuzeaux S; Crizer DM; Driemert P; Ebbels T; Ekman D; Flick B; Giri V; Gómez-Romero M; Haake V; Herold M; Kende A; Lai F; Leonards PEG; Lim PP; Lloyd GR; Mosley J; Namini C; Rice JR; Romano S; Sands C; Smith MJ; Sobanski T; Southam AD; Swindale L; van Ravenzwaay B; Walk T; Weber RJM; Zickgraf FM; Kamp H
Arch Toxicol; 2024 Apr; 98(4):1111-1123. PubMed ID: 38368582
[TBL] [Abstract][Full Text] [Related]
5. SpectraX: A Straightforward Tool for Principal Component Analysis-Based Spectral Analysis.
Yu J; Metwally H; Kolwich J; Tomm H; Klotz R; Liu C; LeBlanc JCY; Covey TR; Ross AC; Oleschuk RD
J Am Soc Mass Spectrom; 2024 Feb; 35(2):397-400. PubMed ID: 38217511
[TBL] [Abstract][Full Text] [Related]
6. Changes in the salivary metabolome in patients with chronic erosive gastritis.
Liu S; Zhang S; Chen H; Zhou P; Yang T; Lv J; Li H; Wang Y
BMC Gastroenterol; 2023 May; 23(1):161. PubMed ID: 37208605
[TBL] [Abstract][Full Text] [Related]
7. Non-targeted metabolomics reveals diagnostic biomarker in the tongue coating of patients with chronic gastritis.
Mu X; Ji C; Wang Q; Liu K; Hao X; Zhang G; Shi X; Zhang Y; Gonzalez FJ; Wang Q; Wang Y
J Pharm Biomed Anal; 2019 Sep; 174():541-551. PubMed ID: 31255854
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling of femoral muscle from rats at different periods of time after death.
Du T; Lin Z; Xie Y; Ye X; Tu C; Jin K; Xie J; Shen Y
PLoS One; 2018; 13(9):e0203920. PubMed ID: 30216363
[TBL] [Abstract][Full Text] [Related]
9. LC-HRMS Metabolomics for Untargeted Diagnostic Screening in Clinical Laboratories: A Feasibility Study.
Rochat B; Mohamed R; Sottas PE
Metabolites; 2018 Jun; 8(2):. PubMed ID: 29914076
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil.
Sasada S; Miyata Y; Tsutani Y; Tsuyama N; Masujima T; Hihara J; Okada M
Oncol Rep; 2013 Mar; 29(3):925-31. PubMed ID: 23232983
[TBL] [Abstract][Full Text] [Related]
11. OMG: Open Molecule Generator.
Peironcely JE; Rojas-Chertó M; Fichera D; Reijmers T; Coulier L; Faulon JL; Hankemeier T
J Cheminform; 2012 Sep; 4(1):21. PubMed ID: 22985496
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease.
Shi X; Wahlang B; Wei X; Yin X; Falkner KC; Prough RA; Kim SH; Mueller EG; McClain CJ; Cave M; Zhang X
J Proteome Res; 2012 Jul; 11(7):3805-15. PubMed ID: 22686559
[TBL] [Abstract][Full Text] [Related]
13. MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics.
Wei X; Sun W; Shi X; Koo I; Wang B; Zhang J; Yin X; Tang Y; Bogdanov B; Kim S; Zhou Z; McClain C; Zhang X
Anal Chem; 2011 Oct; 83(20):7668-75. PubMed ID: 21932828
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach.
Huang Z; Lin L; Gao Y; Chen Y; Yan X; Xing J; Hang W
Mol Cell Proteomics; 2011 Oct; 10(10):M111.007922. PubMed ID: 21799048
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analytical strategy for biomarker identification based on liquid chromatography coupled to mass spectrometry and new candidate confirmation tools.
Mohamed R; Varesio E; Ivosev G; Burton L; Bonner R; Hopfgartner G
Anal Chem; 2009 Sep; 81(18):7677-94. PubMed ID: 19702294
[TBL] [Abstract][Full Text] [Related]
16. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Toyo'oka T; Min JZ; Inagaki S; Higashi T; Kagawa Y
J Proteome Res; 2010 Aug; 9(8):3912-22. PubMed ID: 20557141
[TBL] [Abstract][Full Text] [Related]
17. Quantification of urinary excretion of 1,N6-ethenoadenine, a potential biomarker of lipid peroxidation, in humans by stable isotope dilution liquid chromatography-electrospray ionization-tandem mass spectrometry: comparison with gas chromatography-mass spectrometry.
Chen HJ; Chang CM
Chem Res Toxicol; 2004 Jul; 17(7):963-71. PubMed ID: 15257622
[TBL] [Abstract][Full Text] [Related]
18. Analysis of highly polar metabolites in human plasma by ultra-performance hydrophilic interaction liquid chromatography coupled with quadrupole-time of flight mass spectrometry.
Cai X; Zou L; Dong J; Zhao L; Wang Y; Xu Q; Xue X; Zhang X; Liang X
Anal Chim Acta; 2009 Sep; 650(1):10-5. PubMed ID: 19720166
[TBL] [Abstract][Full Text] [Related]
19. LC-MS metabolomics of polar compounds.
Rojo D; Barbas C; Rupérez FJ
Bioanalysis; 2012 Jun; 4(10):1235-43. PubMed ID: 22651567
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
